Evogene (EVGN) News Today → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free EVGN Stock Alerts $0.66 +0.01 (+1.54%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 3:41 AM | americanbankingnews.comEvogene (NASDAQ:EVGN) Earns Sell Rating from Analysts at StockNews.comMay 16 at 1:42 AM | americanbankingnews.comEvogene (EVGN) Scheduled to Post Earnings on ThursdayMay 10, 2024 | americanbankingnews.comEvogene (NASDAQ:EVGN) Receives New Coverage from Analysts at StockNews.comMay 9, 2024 | prnewswire.comEvogene Schedules First Quarter 2024 Financial Results ReleaseApril 11, 2024 | prnewswire.comBiomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual MeetingApril 2, 2024 | finance.yahoo.comEvogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food IndustryMarch 28, 2024 | prnewswire.comEvogene Announces Filing of Annual Report on Form 20-FMarch 20, 2024 | prnewswire.comEvogene Reports Receipt of Nasdaq Minimum Bid Price NotificationMarch 19, 2024 | prnewswire.comBayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse TestingMarch 8, 2024 | finance.yahoo.comEvogene Ltd. (NASDAQ:EVGN) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | investorplace.comEVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023March 7, 2024 | de.investing.comEvogene: EPS übertrifft Schätzungen um 0,01 $ - Umsatz schlechter als erwartetMarch 7, 2024 | finance.yahoo.comEvogene Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 6, 2024 | finanznachrichten.deAgPlenus Ltd.: AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel HerbicidesMarch 6, 2024 | markets.businessinsider.comHere's what Wall Street expects from Evogene's earnings reportMarch 6, 2024 | benzinga.comEvogene Earnings PreviewMarch 6, 2024 | finance.yahoo.comAgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel HerbicidesMarch 5, 2024 | prnewswire.comCasterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed VarietiesFebruary 28, 2024 | prnewswire.comLavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement RequirementsFebruary 26, 2024 | finance.yahoo.comEvogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024February 26, 2024 | prnewswire.comEvogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024February 22, 2024 | prnewswire.comAgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive OfficerFebruary 21, 2024 | finanznachrichten.deBayer schwankt, deutliche Gewinnmitnahmen bei Renk, Zweifel um Nvidia und auch bei Super Micro Computer ist die Luft rausFebruary 21, 2024 | finance.yahoo.comAgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control SolutionFebruary 21, 2024 | prnewswire.comAgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control SolutionFebruary 20, 2024 | prnewswire.comSyngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-InsecticideFebruary 20, 2024 | businesswire.comSyngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-InsecticideJanuary 17, 2024 | finanznachrichten.deBiomica Ltd.: Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology DrugDecember 5, 2023 | finance.yahoo.comLavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™November 28, 2023 | finance.yahoo.comLavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and BarleyNovember 16, 2023 | benzinga.comIsraeli Cannabis Company Reports Strong Q3 Despite Geopolitical ChallengesNovember 16, 2023 | finance.yahoo.comEvogene Ltd. (NASDAQ:EVGN) Q3 2023 Earnings Call TranscriptNovember 15, 2023 | benzinga.comRecap: Evogene Q3 EarningsNovember 15, 2023 | finance.yahoo.comEvogene Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | markets.businessinsider.comEvogene earnings: here's what Wall Street expectsNovember 14, 2023 | benzinga.comA Preview Of Evogene's EarningsNovember 8, 2023 | finance.yahoo.comLavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial ResultsNovember 2, 2023 | finance.yahoo.comEvogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023October 31, 2023 | finance.yahoo.comColors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing TechnologyAugust 31, 2023 | msn.comEvogene (EVGN) Price Target Increased by 12.50% to 4.59August 21, 2023 | finance.yahoo.comEvogene (EVGN) Could Find a Support Soon, Here's Why You Should Buy the Stock NowAugust 21, 2023 | finance.yahoo.comEvogene Ltd. (NASDAQ:EVGN) Q2 2023 Earnings Call TranscriptAugust 18, 2023 | markets.businessinsider.comLake Street Maintains Buy Rating for Evogene: Here's What You Need To KnowAugust 17, 2023 | markets.businessinsider.comEvogene (EVGN) Receives a Buy from Lake StreetAugust 17, 2023 | finance.yahoo.comEvogene Reports Second Quarter 2023 Financial ResultsAugust 17, 2023 | finance.yahoo.comEvogene (EVGN) Reports Q2 Loss, Lags Revenue EstimatesAugust 16, 2023 | markets.businessinsider.comEvogene earnings preview: what Wall Street is expectingAugust 16, 2023 | msn.comEvogene Q2 2023 Earnings PreviewAugust 15, 2023 | finance.yahoo.comBiomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff CenterAugust 1, 2023 | finance.yahoo.comEvogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023 Get Evogene News Delivered to You Automatically Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Bible Shocker: Have You Seen Elon Musk’s Miracle? (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process. Click here for the full story… EVGN Media Mentions By Week EVGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVGN News Sentiment▼0.000.42▲Average Medical News Sentiment EVGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVGN Articles This Week▼21▲EVGN Articles Average Week Get Evogene News Delivered to You Automatically Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LPCN News Today DRRX News Today ICU News Today CCLD News Today MDAI News Today NMTC News Today THTX News Today IINN News Today XGN News Today FEMY News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVGN) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
